Copeptin and Thirst: Possible Predictive Markers of Effectiveness of Bariatric Surgery?

Recruiting now

Conditions studied: Obesity

In brief

Prospective, non-pharmacological, spontaneous, single-center, interventional study.

Key facts

Study ID

NCT06806787

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

30

Starts

2023-09-13

Expected to finish

2026-03-14

Last updated by the study team

2025-02-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI ≥ 40 in the absence of comorbidities; BMI ≥ 35 associated with at least one comorbidity
• Age ≥ 18 and less than or equal to 65 years
• Written informed consent obtained

You may not qualify if…

• Contraindications to bariatric surgery:
• severe psychiatric illness in the decompensation phase;
• drug or alcohol abuse;
• patient unwilling to follow periodic checkups and a dietary regimen pregnancy or lactation.
• Factors that could alter ADH/copeptin:
• Obesity induced by other endocrinopathies or medications;
• Diabetes mellitus of any type;
• Malignant neoplasms or ongoing acute disease;
• Organ failure or chronic CNS and kidney disease;
• Hydro-electrolyte alterations;
• use of drugs that interfere with pituitary-adrenal axis, diuretics, anti-psychotics and psychopharmacological therapies, GLP1 receptor agonists, estro-progestin therapy.

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.